ALSFRS-R scores Archives

Latest news from the CENTAUR trial puts AMX0035 in the mix

4 September 202030 September 2020Research Information Team4 Comments

Reading Time: 2 minutes This week saw the publication of the Phase 2/3 trial results of the experimental drug cocktail, AMX0035, developed by the pharmaceutical company, Amylyx, and carried out across multiple North American clinics. The paper was published in the New England Journal of Medicine.

Can the progression of MND pause or reverse?

12 December 201528 April 2022Sara Bolton1 Comment

Reading Time: 4 minutes Could there be a small number of people for whom there is a pause or a reversal in their disease progression? A talk at the Symposium on Friday afternoon from Dr Rick Bedlack (Duke University) looked into this very topic. There have been few studies looking into the changing nature of motor neurone disease (MND) progression,…